Developments
One of the most relevant developments of the Biopharmacy and Pharmaceutical Technology area is the extended-release tablet of antiepileptic action that required bioavailability and bioequivalence studies involving volunteers at the Assessment Center for Drug Bioavailability and Bioequivalence (CEBIOBE, in Spanish).
The development resulted in the registration of a proprietary drug with an innovative treatment plan, unlike any other proprietary drug on the market.
Camino Saravia s/n - Pando
C.P. 91000 - Canelones, Uruguay
Phone: (+598) 22920984
info@pctp.org.uy
- Biopharmacy and pharmaceutical technology
- Sensometrics and consumer science